Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo

AA Konou, M Salou, N Vidal, P Kodah… - AIDS Research and …, 2015 - Springer
Background Access to antiretroviral treatment (ART) in resource-limited countries has
increased significantly but scaling-up ART into semi-rural and rural areas is more recent …

Significant impact of non‐B HIV‐1 variants genetic diversity in Gabon on plasma HIV‐1 RNA quantitation

A Mouinga‐Ondémé, A Mabika‐Mabika… - Journal of medical …, 2014 - Wiley Online Library
Evaluations of HIV‐1 RNA viral load assays are lacking in Central Africa. The main objective
of our study was to assess the reliability of HIV‐1 RNA results obtained with three different …

HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains

F Liégeois, V Boué, C Butel… - AIDS Research and …, 2013 - liebertpub.com
The goals of this study conducted in Gabon were to determine the prevalence rate of HIV-1
group O (HIV-1/O) infections and to characterize the genetic diversity of HIV-1/O strains as …

Human T-Lymphotropic virus type 1 and human immunodeficiency virus co-infection in rural Gabon

A Mouinga-Ondémé, L Boundenga… - PLoS …, 2022 - journals.plos.org
Introduction Human T-cell lymphotrophic virus type-1 (HTLV-1) and human
immunodeficiency virus (HIV-1) co-infection occur in many populations. People living with …

Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa

F Taieb, AF Aghokeng, S Eymard-Duvernay… - AIDS research and …, 2014 - liebertpub.com
Editor: The 2013 United Nations Program on HIV/AIDS (UNIAIDS) Report on the global
HIV/AIDS epidemic highlighted significant progress toward the elimination of HIV infection …

Molecular Diversity of the Human Immunodeficiency Virus Type 1 in Metropolitan Cities in Central Africa: An Update of Data

BI Bulanda, BI Bongenya, A Chatte… - World Journal of …, 2020 - library.thepustakas.com
The Human Immunodeficiency Virus (HIV) has a diversity that is equal to the complexity of its
management. The group M (Major) is the dominant group in Sub-Saharan Africa and its …

Molecular and serological pattern of Toxoplasma gondii among rural population in four regions of Gabon

P Makouloutou-Nzassi… - Journal of Public …, 2023 - academicjournals.org
Toxoplasma gondii is an obligatory intracellular parasite that causes a zoonotic disease
capable of infecting nearly all warm-blooded hosts, including humans. However, reports on …

HIV drug resistance testing in a resource limited setting with high viral diversity: The first twenty eight months experience

E Teclaire Ngo-Malabo, P Alain Ngoupo… - Current HIV …, 2017 - ingentaconnect.com
Background: First line antiretroviral therapy in a resource-limited setting consists of
nucleotide and non-nucleotide reverse transcriptase inhibitors. Protease inhibitors are the …

[PDF][PDF] HIV drug resistance after failure of 6 month first-line therapy in a hospital: A case series

A Kusumaningrum, F Ibrahim, E Yunihastuti, B Bela - Acta Med Indones, 2019 - core.ac.uk
This is the first report of HIV drug resistance in RSUPN Dr. Cipto Mangunkusumo. We
reviewed eleven new cases of HIV patients who had virologic failure after 6 months first-line …

Etude des résistances du VIH-1 au traitement antirétroviral et amélioration du suivi virologique des patients vivant avec le VIH dans les pays du Sud

E Guichet - 2016 - theses.hal.science
Quinze ans après la mise en place et l'accès élargi au traitement antirétroviral (TAR) dans
les pays du Sud, la suppression virale, objectif clé de son efficacité, n'est pas atteinte chez …